APLM Apollomics Inc.

Nasdaq N/A


$ 23.30 $ -0.10 (-0.43 %)    

Monday, 27-Oct-2025 12:10:26 EDT
QQQ $ 626.69 $ 0.00 (0 %)
DIA $ 474.55 $ -0.24 (-0.05 %)
SPY $ 683.59 $ 0.82 (0.12 %)
TLT $ 91.57 $ 0.26 (0.28 %)
GLD $ 367.16 $ -3.85 (-1.04 %)
$ 23
$ 23.30
$ 23.01 x 100
$ 23.99 x 100
$ 23.20 - $ 24.89
$ 3.66 - $ 42.12
14,557
na
25.38M
$ 0.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 apollomics-receives-39m-payment-from-launxp-maintains-active-collaboration-on-vebreltinib-development

Pursuant to the Company's Form 6-K filed on July 25, 2025 (the "July 2025 6-K"), Apollomics Inc. ("Apollomics&#...

 nasdaq-cancels-delisting-hearing-for-apollomics-confirms-compliance-with-continued-listing-standards

Apollomics Inc. (NASDAQ:APLM) ("Apollomics" or the "Company"), a California based late-stage clinical biopharma...

Core News & Articles

The Nasdaq Stock Market® (NASDAQ:NDAQ) announced that trading will resume in Apollomics Inc. Class A ordinary shares (NASDAQ:AP...

 apollomics-fy24-eps-5280-up-from-23199-yoy

Apollomics (NASDAQ:APLM) reported quarterly losses of $(52.80) per share. This is a 77.24 percent increase over losses of $(231...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION